INR 72.5
(0.69%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.47 Billion INR | 13.97% |
2022 | 1.29 Billion INR | 43.59% |
2021 | 902.44 Million INR | 4.37% |
2020 | 864.65 Million INR | 21.25% |
2019 | 713.12 Million INR | -40.31% |
2018 | 1.19 Billion INR | -13.65% |
2017 | 1.38 Billion INR | -22.4% |
2016 | 1.78 Billion INR | -7.38% |
2015 | 1.92 Billion INR | -3.66% |
2014 | 1.99 Billion INR | -15.26% |
2013 | 2.35 Billion INR | -9.5% |
2012 | 2.6 Billion INR | 19.02% |
2011 | 2.18 Billion INR | 61.43% |
2010 | 1.35 Billion INR | 61.21% |
2009 | 841.28 Million INR | 8.09% |
2008 | 778.29 Million INR | 52.23% |
2007 | 511.27 Million INR | -5.34% |
2006 | 540.08 Million INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 1.34 Billion INR | 0.0% |
2023 FY | 1.47 Billion INR | 13.97% |
2023 Q4 | 1.47 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 Q4 | 1.29 Billion INR | 0.0% |
2022 FY | 1.29 Billion INR | 43.59% |
2022 Q2 | 1.06 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2021 Q2 | 934.58 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 Q4 | 902.44 Million INR | 0.0% |
2021 FY | 902.44 Million INR | 4.37% |
2021 Q3 | - INR | -100.0% |
2020 Q2 | 743.48 Million INR | 0.0% |
2020 FY | 864.65 Million INR | 21.25% |
2020 Q4 | 864.65 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 FY | 713.12 Million INR | -40.31% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 1.21 Billion INR | 0.0% |
2019 Q4 | 713.12 Million INR | 0.0% |
2018 FY | 1.19 Billion INR | -13.65% |
2018 Q4 | 1.19 Billion INR | 0.0% |
2018 Q1 | - INR | 0.0% |
2017 FY | 1.38 Billion INR | -22.4% |
2016 FY | 1.78 Billion INR | -7.38% |
2015 FY | 1.92 Billion INR | -3.66% |
2014 FY | 1.99 Billion INR | -15.26% |
2013 FY | 2.35 Billion INR | -9.5% |
2012 FY | 2.6 Billion INR | 19.02% |
2012 Q2 | 3.64 Billion INR | 0.0% |
2012 Q4 | 2.6 Billion INR | 0.0% |
2011 FY | 2.18 Billion INR | 61.43% |
2010 FY | 1.35 Billion INR | 61.21% |
2009 FY | 841.28 Million INR | 8.09% |
2008 FY | 778.29 Million INR | 52.23% |
2007 FY | 511.27 Million INR | -5.34% |
2006 FY | 540.08 Million INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aarti Drugs Limited | 24.32 Billion INR | 93.928% |
Albert David Limited | 4.97 Billion INR | 70.345% |
Alembic Limited | 23.28 Billion INR | 93.658% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -213.664% |
Hester Biosciences Limited | 6.62 Billion INR | 77.703% |
Hikal Limited | 24.87 Billion INR | 94.062% |
Ind-Swift Limited | 6.54 Billion INR | 77.435% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | 38.482% |
Unichem Laboratories Limited | 31.69 Billion INR | 95.34% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 97.709% |
Bajaj HealthCare Limited | 7.65 Billion INR | 80.698% |
Brooks Laboratories Limited | 904.45 Million INR | -63.283% |
Eris Lifesciences Limited | 70.48 Billion INR | 97.905% |
Solara Active Pharma Sciences Limited | 23.46 Billion INR | 93.707% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | 31.968% |
Wanbury Limited | 3.43 Billion INR | 57.006% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 94.281% |
Alkem Laboratories Limited | 155.74 Billion INR | 99.052% |
FDC Limited | 24.68 Billion INR | 94.016% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 94.819% |
Gufic Biosciences Limited | 10.92 Billion INR | 86.483% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | 87.325% |
Innova Captab Limited | 13.2 Billion INR | 88.819% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 93.42% |
Ipca Laboratories Limited | 111.01 Billion INR | 98.67% |
Jubilant Pharmova Limited | 115.48 Billion INR | 98.721% |
Lincoln Pharmaceuticals Limited | 7 Billion INR | 78.911% |
Lupin Limited | 239.97 Billion INR | 99.385% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | 55.708% |
Medico Remedies Limited | 961.95 Million INR | -53.523% |
Morepen Laboratories Limited | 12.93 Billion INR | 88.58% |
Nectar Lifesciences Limited | 21.91 Billion INR | 93.26% |
Orchid Pharma Limited | 15.53 Billion INR | 90.496% |
Procter & Gamble Health Limited | 7.94 Billion INR | 81.409% |
RPG Life Sciences Limited | 5.12 Billion INR | 71.205% |
Sigachi Industries Limited | 6.94 Billion INR | 78.725% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.827% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 93.448% |
Themis Medicare Limited | 5.66 Billion INR | 73.927% |
Vaishali Pharma Limited | 799.55 Million INR | -84.704% |
Venus Remedies Limited | 6.26 Billion INR | 76.44% |
Windlas Biotech Limited | 6.26 Billion INR | 76.416% |
ZIM Laboratories Limited | 4.46 Billion INR | 66.948% |
Sakar Healthcare Limited | 3.88 Billion INR | 62.002% |
Aurobindo Pharma Limited | 450.71 Billion INR | 99.672% |
Divi's Laboratories Limited | 154.7 Billion INR | 99.045% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | 86.301% |
Mankind Pharma Limited | 119.63 Billion INR | 98.766% |
Sequent Scientific Limited | 15.4 Billion INR | 90.413% |
Laurus Labs Limited | 83.87 Billion INR | 98.239% |
Neuland Laboratories Limited | 18.32 Billion INR | 91.941% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 96.303% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 98.971% |
Zydus Lifesciences Limited | 292.8 Billion INR | 99.496% |
Amrutanjan Health Care Limited | 3.66 Billion INR | 59.746% |
Wockhardt Limited | 76.49 Billion INR | 98.069% |
Bal Pharma Limited | 3.2 Billion INR | 53.906% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 99.619% |
Bliss GVS Pharma Limited | 12.13 Billion INR | 87.834% |
Par Drugs and Chemicals Limited | 1.01 Billion INR | -45.34% |
Caplin Point Laboratories Limited | 26.97 Billion INR | 94.525% |
Shilpa Medicare Limited | 30.93 Billion INR | 95.226% |
Valiant Laboratories Limited | 3.42 Billion INR | 56.905% |
Ajanta Pharma Limited | 46.38 Billion INR | 96.816% |
Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | 51.579% |
Granules India Limited | 55.2 Billion INR | 97.325% |
Medicamen Biotech Limited | 2.94 Billion INR | 49.857% |
Syncom Formulations (India) Limited | 4.04 Billion INR | 63.505% |
Piramal Enterprises Limited | 826.05 Billion INR | 99.821% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 99.019% |
NATCO Pharma Limited | 69.06 Billion INR | 97.862% |
Suven Life Sciences Limited | 2.84 Billion INR | 48.164% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | 17.114% |
Strides Pharma Science Limited | 58.39 Billion INR | 97.471% |
Indoco Remedies Limited | 21.44 Billion INR | 93.114% |
Alpa Laboratories Limited | 1.82 Billion INR | 19.133% |
Lasa Supergenerics Limited | 1.5 Billion INR | 2.112% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 71.326% |